相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial
Sybil A. A. McAuley et al.
DIABETES CARE (2022)
Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring
Michael Yapanis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)
Investigating the efficacy of baricitinib in new onset type 1 diabetes mellitus (BANDIT)-study protocol for a phase 2, randomized, placebo controlled trial
M. Waibel et al.
TRIALS (2022)
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings
David C. Klonoff et al.
JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2022)
Essential Continuous Glucose Monitoring Metrics: The Principal Dimensions of Glycemic Control in Diabetes
Eslam Montaser et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2022)
Efficacy of a Hybrid Closed-Loop Solution in Patients With Excessive Time in Hypoglycaemia: A Post Hoc Analysis of Trials With DBLG1 System
Pierre-Yves Benhamou et al.
JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2022)
Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial
Sybil A. McAuley et al.
DIABETES CARE (2022)
Real-World Use of a New Hybrid Closed Loop Improves Glycemic Control in Youth with Type 1 Diabetes
Laurel H. Messer et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2021)
Quality of Glycemic Control: Assessment Using Relationships Between Metrics for Safety and Efficacy
David Rodbard
DIABETES TECHNOLOGY & THERAPEUTICS (2021)
Role of Composite Glycemic Indices: A Comparison of the Comprehensive Glucose Pentagon Across Diabetes Types and HbA1c Levels
Suresh Rama Chandran et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2020)
A Review of Continuous Glucose Monitoring-Based Composite Metrics for Glycemic Control
Michelle Nguyen et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2020)
Assessment of Glucose Control Metrics by Discriminant Ratio
Vanessa Moscardo et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2020)
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Tadej Battelino et al.
DIABETES CARE (2019)
Glycaemic variability in diabetes: clinical and therapeutic implications
Antonio Ceriello et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes
Robert A. Vigersky et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2019)
Temporal case-based reasoning for type 1 diabetes mellitus bolus insulin decision support
Daniel Brown et al.
ARTIFICIAL INTELLIGENCE IN MEDICINE (2018)
Metrics to Evaluate Quality of Glycemic Control: Comparison of Time in Target, Hypoglycemic, and Hyperglycemic Ranges with Risk Indices
David Rodbard
DIABETES TECHNOLOGY & THERAPEUTICS (2018)
Glycemic Variability Percentage: A Novel Method for Assessing Glycemic Variability from Continuous Glucose Monitor Data
Thomas A. Peyser et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2018)
Application of Glycemic Variability Percentage: Implications for Continuous Glucose Monitor Utilization and Analysis of Artificial Pancreas Data
Arturo Garcia et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2017)
International Consensus on Use of Continuous Glucose Monitoring
Thomas Danne et al.
DIABETES CARE (2017)
A Simple Composite Metric for the Assessment of Glycemic Status from Continuous Glucose Monitoring Data: Implications for Clinical Practice and the Artificial Pancreas
Irl B. Hirsch et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2017)
Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real-Time Continuous Glucose Monitoring
Ahmed H. El-Laboudi et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2016)
Q-Score: development of a new metric for continuous glucose monitoring that enables stratification of antihyperglycaemic therapies
Petra Augstein et al.
BMC ENDOCRINE DISORDERS (2015)
Evaluation of the Mean Absolute Glucose Change as a Measure of Glycemic Variability Using Continuous Glucose Monitoring Data
Klaus-Dieter Kohnert et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2013)
Normal Reference Range for Mean Tissue Glucose and Glycemic Variability Derived from Continuous Glucose Monitoring for Subjects Without Diabetes in Different Ethnic Groups
Nathan R. Hill et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2011)
Glucose variability is associated with intensive care unit mortality
Jeroen Hermanides et al.
CRITICAL CARE MEDICINE (2010)
Statistical Tools to Analyze Continuous Glucose Monitor Data
William Clarke et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2009)
Improved Quality of Glycemic Control and Reduced Glycemic Variability with Use of Continuous Glucose Monitoring
David Rodbard et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2009)
The Glucose Pentagon: Assessing Glycemic Control of Patients with Diabetes Mellitus by a Model Integrating Different Parameters from Glucose Profiles
Andreas Thomas et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2009)
Interpretation of Continuous Glucose Monitoring Data: Glycemic Variability and Quality of Glycemic Control
David Rodbard
DIABETES TECHNOLOGY & THERAPEUTICS (2009)
FRAX™ and the assessment of fracture probability in men and women from the UK
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2008)
A method for assessing quality of control from glucose profiles
N. R. Hill et al.
DIABETIC MEDICINE (2007)
Evaluation of a new measure of blood glucose variability in diabetes
Boris P. Kovatchev et al.
DIABETES CARE (2006)
Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments
R Breitling et al.
FEBS LETTERS (2004)
分享论文
